 Wegener granulomatosis renal involvement patient survival correlations initial renal function renal histology therapy renal outcome Patient survival renal outcome patients biopsy Wegener granulomatosis renal involvement Fourteen patients dialysis admission patients patients novel protocol methylprednisolone cyclophosphamide median follow-up observation months months exception patient causes Wegener granulomatosis patients alive patients dialysis terminal renal failure months nondialysis group patient chronic dialysis months clinical admission Renal failure due non-compliance immunosuppressive therapy patients Percentage obsolescent glomeruli degree tubulointerstitial lesions active glomerular lesions crescents necroses renal outcome major cause renal functional impairment relapse Wegener granulomatosis years clinical remission prolonged treatment cyclophosphamide years clinical remission patients negative immunohistology second renal biopsy appearance mesangial IgA deposits